Cite
HARVARD Citation
Badar, T. et al. (2014). Ibrutinib: a paradigm shift in management of CLL. Expert review of hematology. 7 (6), pp. 705-717. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Badar, T. et al. (2014). Ibrutinib: a paradigm shift in management of CLL. Expert review of hematology. 7 (6), pp. 705-717. [Online].